Danaher Co. (NYSE:DHR) Shares Sold by Highline Wealth Partners LLC

Highline Wealth Partners LLC reduced its holdings in Danaher Co. (NYSE:DHR) by 0.8% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 7,326 shares of the conglomerate’s stock after selling 58 shares during the period. Highline Wealth Partners LLC’s holdings in Danaher were worth $1,682,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Fort Pitt Capital Group LLC increased its position in shares of Danaher by 3.2% during the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after purchasing an additional 7,421 shares during the period. Good Life Advisors LLC bought a new stake in shares of Danaher during the 3rd quarter worth $217,000. Harvest Portfolios Group Inc. increased its stake in Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after purchasing an additional 2,465 shares in the last quarter. Stifel Financial Corp raised its holdings in shares of Danaher by 1.3% during the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after acquiring an additional 11,216 shares during the period. Finally, Oddo BHF Asset Management Sas purchased a new position in shares of Danaher during the third quarter valued at $24,204,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Down 0.9 %

Shares of NYSE:DHR traded down $2.03 during trading on Friday, hitting $236.06. 1,355,819 shares of the company were exchanged, compared to its average volume of 2,598,840. The firm has a fifty day moving average price of $235.93 and a two-hundred day moving average price of $253.88. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70. The stock has a market cap of $170.50 billion, a price-to-earnings ratio of 45.05, a P/E/G ratio of 4.33 and a beta of 0.83. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the previous year, the company posted $2.02 EPS. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, research analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on DHR shares. Citigroup lowered their price objective on shares of Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a research report on Monday. Guggenheim assumed coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target on the stock. Raymond James dropped their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Stifel Nicolaus boosted their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Finally, Royal Bank of Canada dropped their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $286.80.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.